Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

Kathrine Lederballe Grøn*, Elizabeth V. Arkema, Bente Glintborg, Frank Mehnert, Mikkel Østergaard, Lene Dreyer, Mette Nørgaard, Niels Steen Krogh, Johan Askling, Merete Lund Hetland

*Corresponding author af dette arbejde
18 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology